Imatinib: A Review of its Use in Chronic Myeloid Leukaemia

Author： Moen Marit D. McKeage Kate Plosker Greg L. Siddiqui M. Asif A.

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.2, 2007-01, pp. : 299-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib: A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

By McCormack Paul L. Keam Susan J.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1771-1795

Adis International

Access to resources Recommend Favorite

Imatinib mesylate in the treatment of chronic myeloid leukaemia

By Druker Brian J

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 963-971

Informa Healthcare

Access to resources Recommend Favorite

The use of imatinib appears to be associated with interstitial lung disease (ILD) in patients with chronic myeloid leukaemia (CML)

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Gemtuzumab Ozogamicin: A Review of its Use in Acute Myeloid Leukaemia

By Fenton Caroline Perry Caroline M.

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2405-2427

Adis International

Access to resources Recommend Favorite